Clinical trial Recruiting at 2 sites Observational Ages 18 to 75

AI-enhanced MRE to detect bowel fibrosis in Crohn's disease

Official title: A Prospective, Multi-center Study to Characterize Intestinal Fibrosis in Patients With Crohn's Disease (CD) Using MR Enterography (MRE)-Based Artificial Intelligence

Run by First Affiliated Hospital, Sun Yat-Sen University · NCT06858553 · Data updated 2026-11-12

This project will test whether an AI program applied to magnetic resonance enterography (MRE) scans can accurately identify and characterize bowel wall fibrosis in adults with Crohn's disease who are scheduled for bowel resection.

More Crohn Disease (CD) trials

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment234 (estimated)
SponsorFirst Affiliated Hospital, Sun Yat-Sen University
Academic / other
Locations5 sites (Guangzhou, Guangdong and 4 other locations)
StatusRecruiting
StartedJune 3, 2025
Main results expectedFebruary 28, 2027
Study endsFebruary 28, 2027
Registry record updatedAugust 5, 2025
Trial IDNCT06858553 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (over 18) with a confirmed diagnosis of Crohn's disease who are planning bowel resection for an ileal or colonic stricture and who can undergo MRI with clear MRE images suitable for segmentation are ideal candidates.

Probably not a fit

Patients who cannot have MRI, whose MRE scans are poor quality or contain artifacts, who have anastomotic strictures, or whose lesions are complicated by other diseases are unlikely to benefit from this project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective multicenter observational effort enrolling about 234 adults with Crohn's disease who require ileal or colonic resection for strictures. Preoperative MRE scans will be paired with histological analysis of the resected bowel to train and validate a deep learning model that can detect and grade full-thickness intestinal fibrosis. Participating centers will follow a centralized quality assurance plan, including routine monitoring, double verification of data and specimens, and periodic audits. The project requires clear target-segment boundaries on MRE to enable semi-automatic or automatic segmentation for model development.

Why it matters

Potential benefit: If successful, the AI-enhanced MRE tool could allow noninvasive, more accurate detection of full-thickness bowel fibrosis to help guide medical versus surgical treatment decisions.

How similar studies have gone: Prior radiomics and deep learning work on CT and other imaging modalities has shown promising diagnostic capability, but prospective multicenter development of AI models specifically using MRE matched to histology is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients Over 18 years old with a confirmed diagnosis of CD based on the criteria of ECCO guideline.
2. Planning to receive a bowel resection due to stricture in ileum or colon, and availability of histological specimens of resected intestinal walls matched with MRE are expected to be available.
3. Clear boundaries of the target bowel tract enable accurate semi-automatic or fully automatic intestinal segmentation

Exclusion Criteria:

1. Cannot undergo MRI examination
2. Difficult to obtain suitable tissue after surgery
3. MRE imaging is of poor quality or contains artifacts
4. The target bowel is located at the anastomosis (ie, anastomotic stricture)
5. Intestinal lesions concurrent with other diseases

Where it's running

  • The First Affiliated Hospital,Sun Yat-sen University
    Guangzhou, Guangdong, China
    Recruiting
  • Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
    Hangzhou, Zhejiang, China
    Recruiting
  • Sixth Affiliated Hospital of Sun Yat-sen University
    Guangzhou, Guangdong, China
    Not yet recruiting
  • Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
    Nanjing, Jiangsu, China
    Not yet recruiting
  • Ruijin Hospital, Shanghai Jiaotong University School of Medicine
    Huangpu, Shanghai Municipality, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Reduce ultra-processed foods to help kids with Crohn's stay in remission longer

    This study tests whether and how reducing ultra-processed foods with dietitian guidance helps children and teens with Crohn's disease stay in remission longer.

    Recruiting University Hospital, Motol · Prague and 1 other locations · NCT07884045

  • Endoscopic stricturotomy vs balloon dilation for small bowel Crohn’s stricture

    This trial tests whether endoscopic stricturotomy can be safely and effectively used to treat small bowel fibrotic strictures in Crohn’s disease, compared with endoscopic balloon dilation.

    Recruiting Sixth Affiliated Hospital, Sun Yat-sen University · Guangzhou, Guangdong · NCT07833332

  • Prediction of postoperative recurrence in Crohn's disease after surgery

    A multicenter study will test a multimodal model to predict which Crohn's patients are likely to have disease recur after intestinal resection.

    Recruiting Sixth Affiliated Hospital, Sun Yat-sen University · Guangzhou, Guangdong · NCT07824791

  • Perianal fistula imaging comparison using TPUS, MRI, EUS, and EUA

    This study tests how well four imaging methods—transperineal ultrasound, MRI, endoscopic ultrasound, and examination under anesthesia—detect and describe perianal fistulas in adults with Crohn's disease or unknown cause.

    Recruiting Asian Institute of Gastroenterology, India · Hyderabad, Telanagana · NCT07794410

  • Familial IBD Early Risk

    This study tests whether clinical, environmental, and immune factors in first-degree relatives of people with Crohn’s disease or ulcerative colitis can predict who will develop IBD.

    Recruiting Seattle Children's Hospital · Seattle, Washington · NCT07791862

  • Impact of sucralose on gut health in Crohn's disease

    This study tests whether the non-nutritive sweetener sucralose changes gut bacteria in adults with Crohn's disease compared to healthy controls.

    Recruiting at 3 sites University Hospitals Cleveland Medical Center · Chagrin Falls, Ohio and 2 other locations · NCT07769437

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.